IOVA - Iovance Biotherapeutics, Inc.

Exchange: NASDAQ

IOVA - Iovance Biotherapeutics, Inc.

Exchange: NASDAQ

Tue 14'th Aug 2018

PERIOD 2018-05-15 - 2018-08-14
CHANGE 6.33%
PRICE $15.95





Request Prediction

Iovance Biotherapeutics, Inc. Stock Analysis

Technical stock analysis for Tue 14'th Aug 2018

Buy candidate since 2018-08-10 Gain 8.87%
Shorts 8.00% ( 2018-07-31 )
Cash 163.4 mill
Loans n/a
Beta 2.06
ROA -49.76

Iovance Biotherapeutics, Inc. gained 6.33% in the last trading day, rising from $15.00 to $15.95 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 6 of the last 10 days and is up by 12.32% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.19 million more shares were traded than the day before. In total, 1.84 million shares bought and sold for approximately $29.37 million.


Iovance Biotherapeutics, Inc. has broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $15.68, a level that may pose a second chance to hit a runner. According to fan-theory $19.86 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Iovance Biotherapeutics, Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $14.67 and $13.90. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday August 08, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 64 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $15.00 and $13.60.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Iovance Biotherapeutics, Inc. finds support just below today's level at $15.00. If this is broken, then the next support from accumulated volume will be at $13.60 and $13.40.

Support: $15.00 Price: $15.95 Resistance: $16.35


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.13 (7.55%) between high and low. For the last week, the stock has had a daily average volatility of 7.79%.

Our recommended stoploss: $15.29 (-4.11%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 4 days ago.)

Overall risk:

Very Low Low Medium High Very High


Iovance Biotherapeutics, Inc. holds several positive signals and the break up from the falling trend indicates a possible shift of trend as well. The trend doesn't have to go from falling to rising, it may as well go horizontal or even just decrease the earlier fall rate, but we find the risk-reward to be attractive and expect the stock to perform very well in the short term period. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.

Strong Buy Candidate

Click for Top 5 Strong Buy Candidates
IOVA $15.95 $0.95(6.33%)
IOVA is up $0.95 today, but where's it headed in September?
Zacks Investment Research is releasing its prediction for IOVA based on the 1-3 month system that more than doubles the S&P 500.

Click here – the IOVA analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with